TG Therapeutics | TGTX - Pasivo Circulante

Precio De Mercado
28.43
Cambio Diario
0.47 1.68%
Mensual
-2.17%
Anual
-30.76%
Q1 Expectativa
27.12




Pasivo Circulante Cambio Fecha
AbbVie USD 43.29B 3.9B 2025-12
Alaunos Therapeutics USD 921K 153K 2025-09
Amgen USD 25.49B 3.7B 2025-12
Ardelyx USD 83.39M 1.67M 2025-09
Arrowhead Research USD 347.42M 151.94M 2025-12
Bayer EUR 32.58B 3.63B 2025-12
Biogen USD 3.35B 59.4M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Curis USD 19.37M 745K 2025-06
Gilead Sciences USD 11.81B 485M 2025-12
Infinity Pharmaceuticals USD 12.06M 775K 2023-06
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 87.16M 12.06M 2025-09
Novartis USD 32B 286M 2025-09
Novavax USD 429.87M 40.73M 2025-09
PTC Therapeutics USD 968.43M 102.18M 2025-12
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Verastem USD 59.71M 24.09M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12